These men have demonstrated the tremendous power of translational research and multidisciplinary collaboration. It took their combined expertise — Dr. Batchelor’s experience treating glioblastoma, Dr. Jain’s knowledge of drugs that attack the abnormal blood vessels feeding a tumor, and Dr. Sorensen’s ability to visualize and measure what is happening to a tumor — to show how a new smart drug can work on a completely different type of tumor. Their efforts are leading to novel therapies for brain cancer patients.
You are using an unsupported browser. Please use the latest version of
Chrome, Firefox, Safari or Edge.
![Triple the impact of your support](https://cdn4.giving.massgeneral.org/assets/2409-MGHFund-FYE-Banner.jpg)
Make your 3x MGH Fund gift now.
During the MGH Fund Triple Match Challenge your gift to the MGH Fund will go 3x as far, now until September 30.
Time left to triple your impact:
![The one hundred honoree: Tracy Batchelor, MD, MPH and Gregory Sorensen, MD and Rakesh Jain, PhD](https://cdn4.giving.massgeneral.org/assets/tracy-batchelor-md-mph-and-gregory-sorensen-md-and-rakesh-jain-phd-1.jpg)